FDA Approved: DIAZEPAM — Supplemental Application (Oceanside Pharmaceuticals)

View source ↗

Summary

FDA supplemental approval for Diazepam under Oceanside Pharmaceuticals is recorded, confirming the approval of a supplemental application for diazepam.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcohol Withdrawal Syndrome
• Epilepsy
• Generalized Anxiety Disorder
• Skeletal Muscle Spasm
• Status Epilepticus

Drugs mentioned

• Diazepam (Diazepam)

Snippet

SUPPL AP for DIAZEPAM (DIAZEPAM)